Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2025-12-25 @ 1:03 AM
NCT ID:
NCT03886493
Brief Title:
Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
Official Title:
Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
Study:
NCT03886493
Protocol Section:
NCT03886493